Front Row Advisors LLC Teva Pharmaceutical Industries LTD Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Front Row Advisors LLC holds 200 shares of TEVA stock, worth $3,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$3,592
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TEVA
# of Institutions
611Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$772 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$652 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$581 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$523 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$518 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.9B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...